The cardiology sector has witnessed significant growth in the last 12 months, drawing substantial interest from private equity investors, particularly as more and more hospital employment deals continue to expire. Since the initial surge in consolidation, several new platforms have emerged, and existing ones have expanded their operations into new states. Since January 2023 there have been 22+ transactions within the cardiology space, including 3 new platforms created. While there is still plenty of white space for new platforms within Cardiology, the window to maintain a first-mover advantage is continually shrinking.
Within this evolving landscape, the sector has adapted to broader changing healthcare dynamics, as seen in other specialties. Core procedures and ancillary services continue to transition into outpatient settings, and value-based reimbursement models continue to gain traction, encouraging more physician sellers to explore partnership opportunities. Healthcare private equity investors are increasingly drawn to these models, aiming not only for improved patient outcomes and reduced costs but also for long-term sustainability and profitability.
Even despite current macroeconomic headwinds, this landscape has created an increasingly competitive environment, requiring a careful selection process for cardiology practices considering private equity partnerships. Aligning with a partner who not only understands the intricacies of the sector but also shares a vision for exceptional patient care and clinical autonomy to ensure long-term success is vital. Moreover, a partner’s expertise in service line development, navigating the reimbursement environment, infrastructure development, and geographic expansion are key factors when selecting a partner.
Recent Cardiology Transactions
Date
Target
PE Sponsor
Platform
State
October 2023
Clearwater Cardiovascular Consultants
Lee Equity Partners
Cardiovascular Logistics
FL
September 2023
Southeast Houston Cardiology
N/A
CLS Health
TX
September 2023
Daytona Heart Group
Webster Equity Partners
Cardiovascular Associates of America
FL
September 2023
Central Florida Cardiology Group
Chicago Pacific Founders
Qoros Health
FL
September 2023
The Cardiovascular Center of Florida
Webster Equity Partners
Cardiovascular Associates of America
FL
August 2023
Carolina Vein Center
Cortec Group
Center for Vein Restoration
NC
July 2023
Cardiovascular Associates
Webster Equity Partners
Cardiovascular Associates of America
FL
June 2023
Bay Area Cardiology and Vascular Associates
Webster Equity Partners
Webster Equity Partners
FL
June 2023
James River Cardiology
RC Capital
Initial Platform: Aligned Cardiovascular Partners
VA
June 2023
Shore Heart Group
Webster Equity Partners
Cardiovascular Associates of America
NJ
May 2023
Memorial Katy Cardiology Associates
Ares Management
US Heart & Vascular
TX
April 2023
The Cardiac and Vascular Institute
Webster Equity Partners
Cardiovascular Associates of America
FL
April 2023
Heartland Cardiology
Ares Management
US Heart & Vascular
KS
April 2023
First Coast Heart & Vascular
Lee Equity Partners
Cardiovascular Logistics
FL
April 2023
HeartPlace
Ares Management
US Heart & Vascular
TN
April 2023
American Vascular Associates
Petra Capital & Canopy Capital
Initial Platform: American Vascular Associates
FL
April 2023
Novocardia
Webster Equity Partners
Cardiovascular Associates of America
FL
February 2023
Cardiovascular Institute of Central Florida
Webster Equity Partners
Cardiovascular Associates of America
FL
February 2023
Orion Medical
Ares Management
US Heart & Vascular
TX
February 2023
Cardiovascular Institute of the South
Lee Equity
Initial Platform: Cardiovascular Logistics
LA
January 2023
Colorado Cardiovascular Surgical Associates
DuneGlass Capital
LifeFlow Partners
CO
January 2023
Oregon Vascular Specialists
DuneGlass Capital
LifeFlow Partners
OR
About Our Firm
Physician Growth Partners (PGP) Physician Growth Partners (PGP) is an advisory firm working exclusively with independent physician groups in transactions with private equity.
PGP has completed 15+ transactions in the last 12 months. Our firm is differentiated by:
Senior partner involvement at every stage of the process
Extensive physician practice transaction experience
Unmatched relationships with all key private equity and strategic buyers interested in Cardiology
Educational approach focused on partnership and cultural fit + achieving a market-clearing valuation